Summary
Coca-Cola Company reported strong top-line growth in the first quarter of 2024, with net operating revenues increasing by 3% to $11.3 billion, driven by a robust 13% contribution from price, product, and geographic mix. This growth was achieved despite a 2% decline in worldwide concentrate sales volume and a 6% unfavorable impact from foreign currency fluctuations. Net income attributable to shareowners rose to $3.177 billion, or $0.74 per diluted share, up from $3.107 billion, or $0.72 per diluted share, in the prior year period. The company also announced significant divestitures, including bottling operations in the Philippines, Bangladesh, and India, which generated substantial proceeds and contributed to other income. Despite the positive revenue and net income figures, operating income saw a significant decrease of 36% to $2.141 billion. This was largely due to substantial "Other Operating Charges," including a $760 million impairment charge for the BodyArmor trademark and a $765 million remeasurement of contingent consideration for the fairlife acquisition. The company continues to manage its financial position, with a strong liquidity position and ongoing share repurchase programs. Investors should monitor the BodyArmor trademark performance and the significant ongoing tax litigation with the IRS, which, if unfavorable, could have a material impact.
Financial Highlights
54 data points| Revenue | $11.30B |
| Cost of Revenue | $4.24B |
| Gross Profit | $7.07B |
| SG&A Expenses | $3.35B |
| Operating Income | $2.14B |
| Interest Expense | $382.00M |
| Net Income | $3.18B |
| EPS (Basic) | $0.74 |
| EPS (Diluted) | $0.74 |
| Shares Outstanding (Basic) | 4.31B |
| Shares Outstanding (Diluted) | 4.32B |
Key Highlights
- 1Net operating revenues increased by 3% to $11.3 billion, driven by a strong 13% favorable impact from price, product, and geographic mix.
- 2Diluted Earnings Per Share (EPS) increased to $0.74 from $0.72 year-over-year.
- 3Significant divestitures of bottling operations generated substantial proceeds and contributed to "Other Income (Loss) - net."
- 4Operating income decreased by 36% to $2.141 billion, primarily due to $1.573 billion in "Other Operating Charges," including a $760 million impairment of the BodyArmor trademark and a $765 million remeasurement of contingent consideration for the fairlife acquisition.
- 5The company reported a strong cash position with $10.4 billion in cash and cash equivalents.
- 6Year-over-year, net cash provided by operating activities increased significantly by 230% to $528 million.
- 7The company continues to return capital to shareholders through dividends and share repurchases, with a quarterly dividend of $0.485 per share declared.